Altimmune's drug meets main goal of mid-stage study for alcohol use disorder
Altimmune's drug meets main goal of mid-stage study for alcohol use disorder July 28 (Reuters) - Altimmune ALT.O said on Tuesday its experimental drug met the main goal of a mid-stage trial for alcohol use disorder.
(Reporting by Kamal Choudhury in Bengaluru)
Recent news on Altimmune
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave